APA (7th ed.) Citation

GG, B., C, G., S, L., RA, D., A, N., I, H., . . . S, S. (2026). Pleomorphic rhabdomyosarcoma, outcomes of patients with advanced disease treated with systemic agents: Retrospective study from the global pushing ultra-rare sarcomas towards hope (PUSH) consortium. European journal of cancer (Oxford, England : 1990), 238, 116666. https://doi.org/10.1016/j.ejca.2026.116666

Chicago Style (17th ed.) Citation

GG, Baldi, et al. "Pleomorphic Rhabdomyosarcoma, Outcomes of Patients with Advanced Disease Treated with Systemic Agents: Retrospective Study from the Global Pushing Ultra-rare Sarcomas Towards Hope (PUSH) Consortium." European Journal of Cancer (Oxford, England : 1990) 238 (2026): 116666. https://doi.org/10.1016/j.ejca.2026.116666.

MLA (9th ed.) Citation

GG, Baldi, et al. "Pleomorphic Rhabdomyosarcoma, Outcomes of Patients with Advanced Disease Treated with Systemic Agents: Retrospective Study from the Global Pushing Ultra-rare Sarcomas Towards Hope (PUSH) Consortium." European Journal of Cancer (Oxford, England : 1990), vol. 238, 2026, p. 116666, https://doi.org/10.1016/j.ejca.2026.116666.